Where does Pieris Pharmaceuticals GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pieris Pharmaceuticals GmbH ranks #8,662 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pieris Pharmaceuticals GmbH hold?

Pieris Pharmaceuticals GmbH holds 37 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Pieris Pharmaceuticals GmbH's Innovation Score?

Pieris Pharmaceuticals GmbH has an Innovation Score of 33.6 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pieris Pharmaceuticals GmbH focus on?

Pieris Pharmaceuticals GmbH's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 34 patents, ranking #650 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Pieris Pharmaceuticals GmbH's patent grant rate increasing or decreasing?

Pieris Pharmaceuticals GmbH's recent grant velocity is +57% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Pieris Pharmaceuticals GmbH's patents?

Pieris Pharmaceuticals GmbH's patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pieris Pharmaceuticals GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Pieris Pharmaceuticals GmbH

USPTO PatentsView assignee record - 37 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pieris ranks #8,662 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 5 technology areas.

#8,662
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.6/100): 17.7
avg claims per patent: +57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8662 · Foreign Corporation #8,662 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,662/49,997
PHOTO-FINISH Pandora Media
CPC-NARROW A61K · 5 areas
INNOV-THIN 33.6/100
CLAIMS-RICH 17.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pandora Media, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pieris’s 33.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (38%) Velocity 2.5 pts (7%) Breadth 7.9 pts (24%) Claim depth 10.6 pts (32%)

Qualcomm Incorporated · highest

85
Crystaphase Products · near

34
Daiwa Kasei Kogyo · near

34
Dümmen Group B V · near

34
Infectious Disease… · near

34
Pieris Pharmaceuticals · this assignee

34
3D Lighting… · lowest

7

What this shows Pieris's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Pieris?

Each dot is one of Pieris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pieris’s own 17.7 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pieris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pieris's grants concentrate

Pieris Pharmaceuticals GmbH is a focused PatentsView assignee: 5 CPC subclasses with 91.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (8 grants) versus a trough of 1 in 2016. By volume, Pieris sits between Progressive Casualty Insurance Company and Relativity ODA LLC.

Pieris's three-year grant acceleration

Pieris Pharmaceuticals GmbH shows 7 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Progressive Casua…

37
Prologium Technol…

37
Protec

37
Pandora Media

37
Pioneer DJ Copora…

37
Pulse Finland OY

37
Quotient Technolo…

37
Relativity ODA

37
Pieris Pharmaceut… ◀

37

What this shows Pieris holds 37 patents at rank #8,664, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pieris

By rank, the assignees closest to #8,664 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Pieris's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pieris, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Pieris ranks #650 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Daiwa Kasei Kogyo Kabushiki Kaisha 34 Crystaphase Products, Inc. 34 Infectious Disease Research Institute 34 Dümmen Group B.V. 34

Pieris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Pieris Pharmaceuticals GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.7%
2017	5	13.5%
2018	4	10.8%
2019	4	10.8%
2020	7	18.9%
2021	8	21.6%
2022	4	10.8%
2023	2	5.4%
2024	1	2.7%
2025partial year	1	2.7%

Which technologies does Pieris Pharmaceuticals GmbH patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 34

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 33

C07K - Peptides 32

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 18

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Pieris Pharmaceuticals GmbH's patent record in context - here's where to go next.

Pieris Pharmaceuticals GmbH's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 91.9% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #8,662 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pieris Pharmaceuticals GmbH against Progressive Casualty Insurance Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.